309 related articles for article (PubMed ID: 22307442)
1. A novel GLA mutation in a Fabry family with glucose-6-phosphate dehydrogenase deficiency.
Pisani A; Visciano B; Russo R; Mozzillo GR; Porto C; De Maggio I; Russo R; Pontarelli G; Villani GR; Cianciaruso B; Di Natale P
J Nephrol; 2012; 25(4):582-5. PubMed ID: 22307442
[TBL] [Abstract][Full Text] [Related]
2. Several mutations including two novel mutations of the glucose-6-phosphate dehydrogenase gene in Polish G6PD deficient subjects with chronic nonspherocytic hemolytic anemia, acute hemolytic anemia, and favism.
Jablonska-Skwiecinska E; Lewandowska I; Plochocka D; Topczewski J; Zimowski JG; Klopocka J; Burzynska B
Hum Mutat; 1999; 14(6):477-84. PubMed ID: 10571945
[TBL] [Abstract][Full Text] [Related]
3. Paradoxical Response to Enzyme Replacement Therapy of Fabry Disease Cardiomyopathy.
Frustaci A; Russo MA; Chimenti C
Circ Cardiovasc Imaging; 2016 Aug; 9(8):. PubMed ID: 27486136
[No Abstract] [Full Text] [Related]
4. A novel small insertion mutation, C.1030_1031ins (T) in α-galactosidase A leads to renal variant fabry disease.
Choi JS; Kim CS; Park JW; Bae EH; Ma SK; Choi YD; Kim GH; Yoo HW; Kim SW
Ren Fail; 2012; 34(3):390-3. PubMed ID: 22260214
[TBL] [Abstract][Full Text] [Related]
5. Fabry disease: thirty-five mutations in the alpha-galactosidase A gene in patients with classic and variant phenotypes.
Eng CM; Ashley GA; Burgert TS; Enriquez AL; D'Souza M; Desnick RJ
Mol Med; 1997 Mar; 3(3):174-82. PubMed ID: 9100224
[TBL] [Abstract][Full Text] [Related]
6. Molecular Analysis of Glucose-6-Phosphate Dehydrogenase Gene Mutations in Bangladeshi Individuals.
Sarker SK; Islam MT; Eckhoff G; Hossain MA; Qadri SK; Muraduzzaman AK; Bhuyan GS; Shahidullah M; Mannan MA; Tahura S; Hussain M; Akhter S; Nahar N; Shirin T; Qadri F; Mannoor K
PLoS One; 2016; 11(11):e0166977. PubMed ID: 27880809
[TBL] [Abstract][Full Text] [Related]
7. Stroke and Chronic Kidney Disease in Fabry Disease.
Tapia D; Kimonis V
J Stroke Cerebrovasc Dis; 2021 Sep; 30(9):105423. PubMed ID: 33160817
[TBL] [Abstract][Full Text] [Related]
8. G6PD Ferrara I has the same two mutations as G6PD A(-) but a distinct biochemical phenotype.
Cappellini MD; Sampietro M; Toniolo D; Carandina G; Martinez di Montemuros F; Tavazzi D; Fiorelli G
Hum Genet; 1994 Feb; 93(2):139-42. PubMed ID: 7906668
[TBL] [Abstract][Full Text] [Related]
9. Molecular basis of Fabry disease: mutations and polymorphisms in the human alpha-galactosidase A gene.
Eng CM; Desnick RJ
Hum Mutat; 1994; 3(2):103-11. PubMed ID: 7911050
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of glucose-6-phosphate dehydrogenase deficiency in Pakistani population.
Moiz B; Nasir A; Moatter T; Naqvi ZA; Khurshid M
Int J Lab Hematol; 2011 Dec; 33(6):570-8. PubMed ID: 21507207
[TBL] [Abstract][Full Text] [Related]
11. Fabry disease and G6PD in three family members with priapism: is the nitric oxide pathway to blame?
Backenroth R; Landau EH; Goren M; Raas-Rothschild A
J Sex Med; 2010 Apr; 7(4 Pt 1):1588-91. PubMed ID: 20102445
[TBL] [Abstract][Full Text] [Related]
12. Detection of alpha-galactosidase a mutations causing Fabry disease by denaturing high performance liquid chromatography.
Shabbeer J; Robinson M; Desnick RJ
Hum Mutat; 2005 Mar; 25(3):299-305. PubMed ID: 15712228
[TBL] [Abstract][Full Text] [Related]
13. Nature and frequency of mutations in the alpha-galactosidase A gene that cause Fabry disease.
Eng CM; Resnick-Silverman LA; Niehaus DJ; Astrin KH; Desnick RJ
Am J Hum Genet; 1993 Dec; 53(6):1186-97. PubMed ID: 7504405
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics and mutation spectrum of GLA in Korean patients with Fabry disease by a nationwide survey: Underdiagnosis of late-onset phenotype.
Choi JH; Lee BH; Heo SH; Kim GH; Kim YM; Kim DS; Ko JM; Sohn YB; Hong YH; Lee DH; Kook H; Lim HH; Kim KH; Kim WS; Hong GR; Kim SH; Park SH; Kim CD; Kim SM; Seo JS; Yoo HW
Medicine (Baltimore); 2017 Jul; 96(29):e7387. PubMed ID: 28723748
[TBL] [Abstract][Full Text] [Related]
15. Identification of Fabry Disease in a Tertiary Referral Cohort of Patients with Hypertrophic Cardiomyopathy.
Maron MS; Xin W; Sims KB; Butler R; Haas TS; Rowin EJ; Desnick RJ; Maron BJ
Am J Med; 2018 Feb; 131(2):200.e1-200.e8. PubMed ID: 28943383
[TBL] [Abstract][Full Text] [Related]
16. Novel α-galactosidase A mutation in patients with severe cardiac manifestations of Fabry disease.
Duro G; Musumeci MB; Colomba P; Zizzo C; Albeggiani G; Mastromarino V; Volpe M; Autore C
Gene; 2014 Feb; 535(2):365-9. PubMed ID: 24140492
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel loss-of-function mutation of the GLA gene in a Chinese Han family with Fabry disease.
Zhou C; Huang J; Cui G; Zeng H; Wang DW; Zhou Q
BMC Med Genet; 2018 Dec; 19(1):219. PubMed ID: 30587147
[TBL] [Abstract][Full Text] [Related]
18. G6PD Aures: a new mutation (48 Ile-->Thr) causing mild G6PD deficiency is associated with favism.
Nafa K; Reghis A; Osmani N; Baghli L; Benabadji M; Kaplan JC; Vulliamy TJ; Luzzatto L
Hum Mol Genet; 1993 Jan; 2(1):81-2. PubMed ID: 8490627
[No Abstract] [Full Text] [Related]
19. A novel G6PD deleterious variant identified in three families with severe glucose-6-phosphate dehydrogenase deficiency.
Tong Y; Liu B; Zheng H; Bao A; Wu Z; Gu J; Tan BH; McGrath M; Kane S; Song C; Li Y
BMC Med Genet; 2020 Jul; 21(1):150. PubMed ID: 32680472
[TBL] [Abstract][Full Text] [Related]
20. Detection of large gene rearrangements in X-linked genes by dosage analysis: identification of novel α-galactosidase A (GLA) deletions causing Fabry disease.
Dobrovolny R; Nazarenko I; Kim J; Doheny D; Desnick RJ
Hum Mutat; 2011 Jun; 32(6):688-95. PubMed ID: 21305660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
